| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-161145 | 2000-05-26 | ||
| JP2000161145 | 2000-05-26 | ||
| PCT/JP2001/004381WO2001089582A1 (en) | 2000-05-26 | 2001-05-25 | Preventives and remedies for pulmonary hypertension |
| Publication Number | Publication Date |
|---|---|
| AU2001258836A1true AU2001258836A1 (en) | 2001-12-03 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001258836AAbandonedAU2001258836A1 (en) | 2000-05-26 | 2001-05-25 | Preventives and remedies for pulmonary hypertension |
| Country | Link |
|---|---|
| US (1) | US7309693B2 (en) |
| AU (1) | AU2001258836A1 (en) |
| WO (1) | WO2001089582A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2990394A1 (en) | 2001-11-30 | 2016-03-02 | Biogen MA Inc. | Antibodies against monocyte chemotactic proteins |
| DE60332847D1 (en)* | 2002-09-12 | 2010-07-15 | Chemo Sero Therapeut Res Inst | HUMAN ANTI-HUMAN MCP-1 ANTI-CORPER AND ANTIBODY PERFRAGMENT THEREOF |
| WO2004071573A2 (en)* | 2003-02-07 | 2004-08-26 | The Johns Hopkins University | Hypoxia induced mitogenic factor |
| CA2544924A1 (en)* | 2003-11-05 | 2005-05-19 | Centocor, Inc. | Methods and compositions for treating mcp-1 related pathologies |
| WO2007021807A1 (en)* | 2005-08-12 | 2007-02-22 | Schering Corporation | Mcp1 fusions |
| US20080076120A1 (en)* | 2006-09-14 | 2008-03-27 | Millennium Pharmaceuticals, Inc. | Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders |
| EP2042516A1 (en)* | 2007-09-27 | 2009-04-01 | Protaffin Biotechnologie AG | Glycosaminoglycan-antagonising MCP-1 mutants and methods of using same |
| NZ591187A (en)* | 2008-08-20 | 2012-07-27 | Probiodrug Ag | Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe) |
| EP2391645A1 (en)* | 2009-01-30 | 2011-12-07 | Protaffin Biotechnologie AG | Glycosaminoglycan-antagonising mcp-i mutants and methods of using same |
| US8524217B2 (en) | 2010-05-11 | 2013-09-03 | Merck Sharp & Dohme Corp. | MCP1-Ig fusion variants |
| WO2015110526A1 (en) | 2014-01-22 | 2015-07-30 | Antagonis Biotherapeutics Gmbh | Novel glycosaminoglycan-antagonising fusion proteins and methods of using same |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5739103A (en) | 1993-11-12 | 1998-04-14 | Dana-Farber Cancer Institute | Chemokine N-terminal deletion mutations |
| US5459128A (en) | 1993-11-12 | 1995-10-17 | Dana-Farber Cancer Institute | Human monocyte chemoattractant protein-1 (MCP-1) derivatives |
| CA2198988A1 (en) | 1997-03-03 | 1998-09-03 | Mai Nguyen | P28 bap31 a bcl-2 associated protein and use thereof for the modulation of apoptosis |
| US6133502A (en)* | 1997-03-10 | 2000-10-17 | Takeda Chemical Industries, Ltd. | Monocyte chemoattractant protein and its receptor transgenic animal |
| EP0887081B1 (en)* | 1997-06-27 | 2003-04-23 | Smithkline Beecham Corporation | Human serum glucocorticoid regulated kinase, a target for chronic renal disease and diabetic nephropathy |
| JPH1149700A (en) | 1997-07-31 | 1999-02-23 | Toray Ind Inc | Therapeutic agent for pulmonary disease |
| WO1999025686A1 (en)* | 1997-11-18 | 1999-05-27 | Teijin Limited | Cyclic amine derivatives and their use as drugs |
| JP2000161145A (en)* | 1998-12-02 | 2000-06-13 | Isuzu Motors Ltd | Fuel injection control device for multiple cylinder engine |
| US20040185450A1 (en)* | 2003-03-21 | 2004-09-23 | Heavner George A. | MCP-1 mutant proteins, antibodies, compositions, methods and uses |
| CA2544924A1 (en)* | 2003-11-05 | 2005-05-19 | Centocor, Inc. | Methods and compositions for treating mcp-1 related pathologies |
| Publication number | Publication date |
|---|---|
| US20030162737A1 (en) | 2003-08-28 |
| US7309693B2 (en) | 2007-12-18 |
| WO2001089582A1 (en) | 2001-11-29 |
| Publication | Publication Date | Title |
|---|---|---|
| AU2001294814A1 (en) | Pumpcn compositions and uses thereof | |
| AU2001246876A1 (en) | Remedies | |
| AU2001246877A1 (en) | Remedies | |
| AU2001251136A1 (en) | Compositions and methods for promoting wound healing | |
| AU2002215116A1 (en) | Expander | |
| AU2001261490A1 (en) | Paper sizing compositions and methods | |
| AU2002248232A1 (en) | Spiral couplers | |
| AU2001280604A1 (en) | Compositions comprising icariside i and anhydroicaritin and methods for making the same | |
| AU2001248742A1 (en) | Compositions for promoting sleep | |
| AU2002224866A1 (en) | Homocinetic fixed joint | |
| AU2001292864A1 (en) | Methods and compositions for modulating angiogenesis | |
| AU2001234782A1 (en) | Compositions and methods for promoting healthy joints | |
| AU2000241427A1 (en) | Duct joint structure | |
| AU2002211717A1 (en) | Stresscopins and their uses | |
| AU2002210925A1 (en) | Preventives/remedies for portal hypertension | |
| AU2001258836A1 (en) | Preventives and remedies for pulmonary hypertension | |
| AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
| AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
| AU2002222676A1 (en) | Preventives or remedies for endometriosis | |
| AU2001232271A1 (en) | Preventives/remedies for postoperative stress | |
| AU2002224133A1 (en) | Remedies for dermatophytosis | |
| AU7626201A (en) | Stage construction | |
| AU5571799A (en) | Angiogenesis inhibitors and uses thereof | |
| AU2001275667A1 (en) | Homocinetic joint | |
| AU2001252062A1 (en) | Steatosis-modulating factors and uses thereof |